NEXT Financial Group, Inc - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,0000.0%890.0%0.00%
Q2 2021$1,0000.0%890.0%0.00%
Q1 2021$1,0000.0%890.0%0.00%
Q4 2020$1,00089
+50.8%
0.00%
Q4 2019$0
-100.0%
590.0%0.00%
Q3 2019$1,0000.0%590.0%0.00%
Q2 2019$1,0000.0%590.0%0.00%
Q1 2019$1,0000.0%590.0%0.00%
Q4 2018$1,0000.0%590.0%0.00%
Q3 2018$1,00059
+18.0%
0.00%
Q4 2016$0500.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders